• Julie Garlikov, Chief Commercial Officer of Sherlock Biosciences

  • Jun 6 2023
  • Length: 53 mins
  • Podcast

Julie Garlikov, Chief Commercial Officer of Sherlock Biosciences

  • Summary

  • Julie Garlikov, Chief Commercial Officer of Sherlock Biosciences that is responsible for driving commercial strategy, product innovation and go to market plans to bring novel diagnostic products to the consumer market. 

    Here are some key moments from our conversation:

    • Brief introduction of yourself and what you do. (00:40)
    • What did your transition look like that led you to this company? (02:54)
    • You have an atypical background for what you do. What is your background and how do you think it serves in your current role? (05:37)
    • How do you approach leadership? (07:15)
    • How do you lead now in terms of the VUCA nature of the world today? (15:33)
    • How do you support your people be successful and to be more resilient? (16:56)
    • How would you describe your true north as a leader? (19:36)
    • What are your style and tips to help others to do their best work? (33:30)
    • What are some of your biggest challenges in your leadership journey? (35:05)
    • How do you navigate disappointment? (36:42)
    • How do you do your best as far as keeping yourself ready for a potential disruption in the market place? (40:29)
    • What do you do to help yourself recharge and rejuvenate to stay on top of your game? (44:06)
    • What one key piece of advice you can leave to our listeners? (46:16)
    Show More Show Less

What listeners say about Julie Garlikov, Chief Commercial Officer of Sherlock Biosciences

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.